CSIMarket



Amgen Inc   (AMGN)
Other Ticker:  
 
 

AMGN's Free Cash Flow Growth by Quarter and Year

Amgen Inc 's Free Cash Flow results by quarter and year




AMGN Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 2,808.00 2,153.00 2,514.00
III Quarter September - 2,418.00 3,368.00 3,377.00
II Quarter June - 1,931.00 2,842.00 1,414.00
I Quarter March 2,164.00 2,104.00 2,134.00 1,845.00
FY   2,164.00 9,261.00 10,497.00 9,150.00



AMGN Free Cash Flow first quarter 2022 Y/Y Growth Comment
Amgen Inc achieved in the first quarter 2022, above Company average Free Cash Flow improvement of 2.85% year on year, to $ 2,164.00 millions.

Looking into first quarter 2022 results within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Free Cash Flow growth. While Amgen Inc ' s Free Cash Flow increase of 2.85% ranks overall at the positon no. 1085 in the first quarter 2022.




AMGN Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 30.42 % -14.36 % -21.29 %
III Quarter September - -28.21 % -0.27 % 3.18 %
II Quarter June - -32.05 % 100.99 % -32.73 %
I Quarter March 2.85 % -1.41 % 15.66 % -32.34 %
FY   - -11.77 % 14.72 % -19 %

Financial Statements
Amgen Inc 's first quarter 2022 Free Cash Flow $ 2,164.00 millions AMGN's Income Statement
Amgen Inc 's first quarter 2021 Free Cash Flow $ 2,104.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Free Cash Flow Growth >>


AMGN Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 16.13 % -36.07 % -25.56 %
III Quarter September - 25.22 % 18.51 % 138.83 %
II Quarter June - -8.22 % 33.18 % -23.36 %
I Quarter March -22.93 % -2.28 % -15.12 % -42.24 %
FY (Year on Year)   - -11.77 % 14.72 % -19 %




Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #89
Overall #1085

Free Cash Flow Y/Y Growth Statistics
High Average Low
19.9 % 1.66 % -14.5 %
(Sep. 30, 2005)   (June 30. 2013)
Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #89
Overall #1085
Free Cash Flow Y/Y Growth Statistics
High Average Low
19.9 % 1.66 % -14.5 %
(Sep. 30, 2005)   (June 30. 2013)

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Amgen Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
5931.25 % 99.87 % -100 %
(June 30. 2004)  


AMGN's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2022 Amgen Inc disclosed fall in Free Cash Flow sequentially by -22.93% to $ 2,164.00 millions, from $ 2,808.00 millions achived a quarter before.

When you evaluate current shortcoming in the quarter, you must assume, that usually I. Quarter performance emerge weaker in contrast to the preciding period, Blake K. Brown, an industry insider situated in Toronto added.

Within Biotechnology & Pharmaceuticals industry 12 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Amgen Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1075.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #13
Healthcare Sector #77
Overall #1075
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #13
Healthcare Sector #77
Overall #1075
Free Cash Flow Q/Q Growth Statistics
High Average Low
5931.25 % 99.87 % -100 %
(June 30. 2004)  


AMGN's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2022 Amgen Inc realized fall in Free Cash Flow from the forth quarter by -22.93% to $ 2,164.00 millions, from $ 2,808.00 millions declared a quarter before.

When you analyse present downturn in the I. Quarter 2022, you suppose to take into consideration, that commonly I. Quarter 2022 results occur softer relative to the forth quarter, Blake K. Brown, an industry insider situated in Toronto mentioned.

Within Biotechnology & Pharmaceuticals industry 12 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Amgen Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1075.


Amgen Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Free Cash Flow 12 Months Ending $ 10,225.00 $ 10,141.00 $ 9,372.00 $ 10,215.00 $ 11,099.00
Y / Y Free Cash Flow Growth (TTM) -7.87 % -8.68 % -18.37 % -11.37 % 10.08 %
Year on Year Free Cash Flow Growth Overall Ranking # 1325 # 528 # 1818 # 1818 # 1278
Seqeuential Free Cash Flow Change (TTM) 0.83 % 8.21 % -8.25 % -7.96 % -0.05 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 1085 # 254 # 737 # 1946 # 1085




Cumulative Free Cash Flow growth Comment
Amgen Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Dec 31 2021. If the fiscal year would end in Mar 31 2022, Amgen Inc 's annual Free Cash Flow decline would be -7.87% year on year to $10,225 millions.

In the Healthcare sector 105 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 528 to 1325.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
19.9 %
1.66 %
-14.5 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 106
Overall # 1325

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
145.53 %
11.77 %
-18.83 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 89
S&P 500 # 1085
Cumulative Free Cash Flow growth Comment
Amgen Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Dec 31 2021. If the fiscal year would end in Mar 31 2022, Amgen Inc 's annual Free Cash Flow fall would be -7.87% year on year to $10,225 millions.

In the Healthcare sector 105 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 528 to 1325.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
19.9 %
1.66 %
-14.5 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 106
Overall # 1325

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
145.53 %
11.77 %
-18.83 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 89
S&P 500 # 1085




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
AMGN's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for AMGN's Competitors
Free Cash Flow Growth for Amgen Inc 's Suppliers
Free Cash Flow Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Free Cash Flow fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2022
Incyte Corp4.68%$ 4.680 millions
Lantheus Holdings Inc 4.54%$ 4.543 millions
Vertex Pharmaceuticals Inc3.82%$ 3.816 millions
Amgen Inc 2.85%$ 2.852 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VIEW's Profile

Stock Price

VIEW's Financials

Business Description

Fundamentals

Charts & Quotes

VIEW's News

Suppliers

VIEW's Competitors

Customers & Markets

Economic Indicators

VIEW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071